Market Announcement 30 September 2026 30 September 2026 Market Announcement 1/1 ASX Limited ASX Customer Service Centre 131 279 | asx.com.au Paradigm Biopharmaceuticals Limited (ASX: PAR) – Continuation of Suspension from Quotation The securities of Paradigm Biopharmaceuticals Limited (‘PAR’) will be suspended from quotation immediately in accordance with Listing Rule 17.3. Having regard to the announcement of the appointment of voluntary administrators released on the market announcements platform on Wednesday, 30 September 2026, ASX has determined that PAR’s financial condition is not adequate to warrant the continued quotation of its securities and therefore PAR is in breach of Listing Rule 12.2. The suspension will continue until ASX is satisfied that PAR is in compliance with the Listing Rules, including Listing Rule 12.2, and that it is otherwise appropriate for PAR’s securities to be reinstated to quotation. Issued by ASX Compliance